Media Summary: Tannaz Ramezanli, CDER Office of Generic Drugs, discusses Priyanka Ghosh, PhD, Acting Team Lead from the Division of Therapeutic Performance (DTP-I) delivers the introduction to the ... Tannaz Ramezanli from the Division of Therapeutic Performance in the Office of
Product Development Considerations For Generic - Detailed Analysis & Overview
Tannaz Ramezanli, CDER Office of Generic Drugs, discusses Priyanka Ghosh, PhD, Acting Team Lead from the Division of Therapeutic Performance (DTP-I) delivers the introduction to the ... Tannaz Ramezanli from the Division of Therapeutic Performance in the Office of This presentation explored general constraints in dry powder inhaler (DPI) formulation and manufacturing, while discussing ... This presentation assessed Critical Quality Attributes (CQA) risks for oral solution and suspension products and described first ... Hirten Patel, PhD, Staff Fellow from the Division of Bioequivalence II (DB-II) presents the Practical
